RxDoctor Payments Data

Justice Oranefo, MD

Clinical Cardiac Electrophysiology · Boise, IDNPI 1467804302

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 34.6% of the total. 2025 is the largest year on record at $8,710, more than ten times the $45 reported in 2020.

$29,779in general payments, 2019–2025

Across 321 payments — averaging $92.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$10K
  • Medtronic$7K
  • Biosense Webster, Inc.$5K
  • Biotronik Inc.$4K
  • Abbott$3K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$455
  • plus $1K from 7 others

What the payments were for

  • Travel & lodging$12,67643%
  • Food & beverage$16,55656%
  • Education$5462%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$32,160
Medicare patients
429
Services billed
599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amiodarone Hcl16$670
Flecainide Acetate13$369
Famotidine12$92
Pantoprazole Sodium12$69

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →